A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus

Exclusion Criteria

• •Patient has other significant ocular disease in study eye, including glaucoma.
• •Patient has any active infection in the study eye.
• •Patient has uncontrolled systemic illness (i.e., uncontrolled blood pressure, uncontrolled diabetes mellitus).
• •Patient has experienced a significant increase in intraocular pressure following a prior treatment with topical or intravitreal steroidal medication.
• •Patient has received the OZURDEX® implant before in the study eye.